ออฟไลน์ด้วยแอป Player FM !
Tim Spong, Founder - VistaPath Bio
Manage episode 294491890 series 2519822
Sponsored by Peter Fasse of Fish & Richardson: https://www.fr.com/team/j-peter-fasse/
To Join Sal's Syndicate: Click Here
A terrible error in a lab led Tim Spong to start a company to improve the reliability and efficiency of pathology labs; big industry players are noticing. This interview was part of my due diligence on Tim’s startup, VistaPath Bio. Subsequently, I invested in the company.
Highlights include:
- Sal Daher Introduces Tim Spong, Co-Founder of VistaPath Bio
- “Fast forward a hundred years, even if you walked into some of the best labs in the country, it's still a room full of people cutting tissue and staining tissue and sitting over jars.”
- “…VistaPath is really aiming to do is build the next generation pathology lab using automation, AI, advanced imaging practices, and then put that into every lab in the world…”
- “The rest of the time and a lot of the costs is spent in these labs, in histology labs, making the slides so that a pathologist can render a diagnosis.”
- The Horror Story that Motivates Tim Spong to Improve the Lab Sample Workflow
- How Tim Spong Connected with His Co-founder Ben Burley
- “When I decided to actually quit my job and do it, it was really with him. We made that leap together. Like I said, he is amazing. I couldn't imagine getting this far without him.”
- VistaPath Has Had to Overcome Investors’ Lack of Interest in Pathology
- VistaPath Has a Smart Benchtop for Grossing of Samples that Is Equipped with Cameras to Reduce Error and Automate the Process
- VistaPath Business Model
- “What we wanted to do with our business model is make our product something that anybody could have, any lab could afford…”
- “…our initial evaluations, we're already seeing that we're more accurate than humans, much faster than humans.”
- “We really strove and worked a long time to make our products something that someone can take out of a box, plug into a lab, it's an easy-to-use interface, and they can use it as part of their workflow immediately.”
- Sal Daher Is Considering Making an Investment in VistaPath Bio
- Sal Daher Invites Accredited Investors to Join His Syndicate List
- Tim’s Entrepreneurial Journey
- Tim Spong Met His Wife at a Pathology Lab
- Tim Spong Credits Advisors for Helping Him Decide to Become a Founder
- “Some people have led us to some of our best advisors and investors were investors that actually turned us down.”
- Tim Spong Encourages Industry Experts to Start Companies to Solve the Problems they See First-Hand
310 ตอน
Manage episode 294491890 series 2519822
Sponsored by Peter Fasse of Fish & Richardson: https://www.fr.com/team/j-peter-fasse/
To Join Sal's Syndicate: Click Here
A terrible error in a lab led Tim Spong to start a company to improve the reliability and efficiency of pathology labs; big industry players are noticing. This interview was part of my due diligence on Tim’s startup, VistaPath Bio. Subsequently, I invested in the company.
Highlights include:
- Sal Daher Introduces Tim Spong, Co-Founder of VistaPath Bio
- “Fast forward a hundred years, even if you walked into some of the best labs in the country, it's still a room full of people cutting tissue and staining tissue and sitting over jars.”
- “…VistaPath is really aiming to do is build the next generation pathology lab using automation, AI, advanced imaging practices, and then put that into every lab in the world…”
- “The rest of the time and a lot of the costs is spent in these labs, in histology labs, making the slides so that a pathologist can render a diagnosis.”
- The Horror Story that Motivates Tim Spong to Improve the Lab Sample Workflow
- How Tim Spong Connected with His Co-founder Ben Burley
- “When I decided to actually quit my job and do it, it was really with him. We made that leap together. Like I said, he is amazing. I couldn't imagine getting this far without him.”
- VistaPath Has Had to Overcome Investors’ Lack of Interest in Pathology
- VistaPath Has a Smart Benchtop for Grossing of Samples that Is Equipped with Cameras to Reduce Error and Automate the Process
- VistaPath Business Model
- “What we wanted to do with our business model is make our product something that anybody could have, any lab could afford…”
- “…our initial evaluations, we're already seeing that we're more accurate than humans, much faster than humans.”
- “We really strove and worked a long time to make our products something that someone can take out of a box, plug into a lab, it's an easy-to-use interface, and they can use it as part of their workflow immediately.”
- Sal Daher Is Considering Making an Investment in VistaPath Bio
- Sal Daher Invites Accredited Investors to Join His Syndicate List
- Tim’s Entrepreneurial Journey
- Tim Spong Met His Wife at a Pathology Lab
- Tim Spong Credits Advisors for Helping Him Decide to Become a Founder
- “Some people have led us to some of our best advisors and investors were investors that actually turned us down.”
- Tim Spong Encourages Industry Experts to Start Companies to Solve the Problems they See First-Hand
310 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ